AI Article Synopsis

  • A study explored the potential of serum autotaxin (ATX) as a predictor for liver-related events (LRE) in patients with primary biliary cholangitis (PBC).
  • During a median follow-up of 9.7 years of 190 untreated patients, those with ATX levels ≥1.086 mg/L experienced significantly more LRE compared to those with lower levels (33.3% vs 3.6%).
  • The research suggests that ATX is a strong independent predictor for LRE, outperforming existing markers, and aligns with findings from a separate validation cohort of PBC patients.

Article Abstract

Introduction: A straightforward, reliable, and noninvasive method for predicting the development of liver-related events (LRE) in primary biliary cholangitis (PBC) has not been attained thus far. This study investigated whether serum autotaxin (ATX) could predict LRE in patients with PBC.

Methods: This retrospective multicenter investigation included 190 biopsy-proven untreated patients with PBC. All subjects were followed for at least 1 year, during which time the prevalence of LRE, including newly developing hepatocellular carcinoma, esophagogastric varices, ascites, and hepatic encephalopathy, was investigated in relation with ATX levels at the time of liver biopsy.

Results: During the median follow-up period of 9.7 years, LRE were observed in 22 patients (11.6%). The area under the receiver operating characteristic curve and cutoff value of serum ATX for predicting LRE were 0.80 and 1.086 mg/L, respectively. Patients with serum ATX ≥1.086 had a significantly higher cumulative incidence of LRE compared with patients with ATX < 1.086 (33.3% vs 3.6%, P < 0.00001). Notably, the predictive capability of ATX for LRE in patients with PBC surpassed that of FIB-4, ALBI, APRI, and Mac-2-binding protein glycan isomer. A multivariate Cox proportional hazards model revealed ATX as an independent associated factor for LRE (hazard ratio 6.24, 95% confidence interval 1.87-20.80, P = 0.003) along with Nakanuma stage (hazard ratio 2.75, 95% confidence interval 1.52-4.99, P < 0.001). These results were closely replicated in a serologically diagnosed PBC validation cohort (n = 32).

Discussion: Serum ATX levels may serve as a predictive marker for LRE in patients with PBC.

Download full-text PDF

Source
http://dx.doi.org/10.14309/ctg.0000000000000779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671064PMC

Publication Analysis

Top Keywords

lre patients
12
patients pbc
12
serum atx
12
lre
9
serum autotaxin
8
liver-related events
8
patients
8
primary biliary
8
biliary cholangitis
8
atx
8

Similar Publications

 Texture and radiomic analysis characterize the lesion's phenotype and evaluate its microenvironment in quantitative terms. The aim of this study was to investigate the role of textural features of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET/CT) images in differentiating patients with cardiac sarcoidosis (CS) from patients with physiologic myocardial uptake.  This is a retrospective, single-center study of 67 patients, 17 diagnosed CS patients, and 50 non-CS patients.

View Article and Find Full Text PDF

Background: Serum ferritin has been suggested as a potential biomarker associated with disease progression in metabolic dysfunction-associated steatotic liver disease (MASLD).

Aims: We investigated the association between serum ferritin levels and liver-related events (LREs) in individuals with steatotic liver disease (SLD).

Methods: This cohort study included 17,560 adults with SLD (MASLD [n = 15,744], MASLD with increased alcohol intake (MetALD) [n = 1103] and cryptogenic SLD [n = 713]) without LRE at baseline.

View Article and Find Full Text PDF
Article Synopsis
  • A study explored the potential of serum autotaxin (ATX) as a predictor for liver-related events (LRE) in patients with primary biliary cholangitis (PBC).
  • During a median follow-up of 9.7 years of 190 untreated patients, those with ATX levels ≥1.086 mg/L experienced significantly more LRE compared to those with lower levels (33.3% vs 3.6%).
  • The research suggests that ATX is a strong independent predictor for LRE, outperforming existing markers, and aligns with findings from a separate validation cohort of PBC patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to improve the prediction of liver-related events (LRE) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) by combining the Fibrosis-4 (FIB-4) index with genetic polymorphism data.
  • Researchers enrolled 1,304 Japanese patients, identifying key genotypes associated with LRE while tracking outcomes over an 8.1-year follow-up period, during which 96 LREs occurred.
  • The findings suggested that a two-step screening strategy using the FIB-4 index followed by genetic assessment effectively identifies high-risk patients, with notable differences in survival rates and LRE development across risk groups.
View Article and Find Full Text PDF

Analysis of the impact on sexual function in early-onset overweight male patients with rectal cancer following robotic surgery.

J Robot Surg

September 2024

Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.

Article Synopsis
  • The study investigates how robotic radical resection (R-RE) of rectal cancer affects sexual function in younger, overweight men, compared to traditional laparoscopic radical resection (L-RE).
  • A retrospective analysis of male patients under 50 who had rectal cancer was conducted, measuring sexual function through the International Index of Erectile Function (IIEF) at various postoperative intervals.
  • Results showed that while both R-RE and L-RE patients experienced a decline in sexual function after surgery, the R-RE group recovered more quickly, with significantly improved scores at 6 months post-op compared to 12 months for the L-RE group.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!